<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02570867</url>
  </required_header>
  <id_info>
    <org_study_id>FirstJinanU</org_study_id>
    <nct_id>NCT02570867</nct_id>
  </id_info>
  <brief_title>Functional Brain Changes of Primary Open-angle Glaucoma Patients</brief_title>
  <official_title>Study on the Changes of Brain Function in Primary Open-angle Glaucoma Patients With fMRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qing Zhou</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Jinan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Structural and functional brain changes of primary open-angle glaucoma patient will be
      examined with fMRI. POAG patients and control group were examined with 3.0T magnetic
      resonance imaging. The gray matter, white matter and cerebrospinal fluid volume images will
      be obtained and analysed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      More and more researches showed that nerve damage in glaucoma is not limited in the optic
      nerve, but also involved the visual pathway, including the optic chiasm, optic beam, lateral
      geniculate body, optic radiation and visual cortex. Furthermore, the central nervous system
      changes may be earlier than visual field and the optic nerve morphology change. Tomography
      (OCT), laser polarimetry 0ptical (SLP), evoked potential scanning (VEP) can not accurately
      reflect the central nervous system changes caused by glaucoma.

      In recent years, magnetic resonance diffusion tensor imaging (DTI), blood oxygen level
      dependent functional magnetic resonance imaging(fMRI- BOLD) and voxel-based Morphometry（VBM)
      is widely used in clinical practice. The differences in the density and volume of brain
      tissue could be analyzed with VBM which had the advantages of comprehensive, objective and
      repeatable. Studies have indicated that patients with POAG can lead to a wide range of
      changes in the cerebral cortex which are associated with the severity of glaucoma.

      Participants in the study will be assigned to primary open-angle glaucoma (POAG) patients or
      healthy volunteers. Two groups will be received 3.0T functional magnetic resonance
      imaging（fMRI) and eye examination including visual acuity, visual field, intraocular
      pressure, anterior chamber angle, corneal thickness and optic nerve fiber thickness. We hope
      this trial will reveal the patterns and structural differences of brain function
      abnormalities between the POAG patents and the normal people. And the same time, the
      correlation between brain gray changes and visual field and retinal nerve fiber layer
      thickness will be analysed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of Brain Function</measure>
    <time_frame>18 months</time_frame>
    <description>The gray matter, white matter and cerebrospinal fluid volume images will be obtained with 3.0T magnetic resonance imaging. The two groups will be compared by Two Sample T-Test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between brain gray changes and retinal nerve fiber layer thickness</measure>
    <time_frame>18 months</time_frame>
    <description>Brain grey matter volume will be measured with 3.0T magnetic resonance imaging and the optic nerve fiber layer thickness were measured with OCT. The correlation of the two will be analysed.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>normal control group</arm_group_label>
    <description>Normal control group: healthy volunteers will be received Functional magnetic resonance imaging（fMRI) and eye examination including visual acuity, visual field, intraocular pressure, anterior chamber angle, corneal thickness and optic nerve fiber thickness one time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>POAG group</arm_group_label>
    <description>POAG: The primary open angle glaucoma cases were will be received Functional magnetic resonance imaging（fMRI) and eye examination including visual acuity, visual field, intraocular pressure, anterior chamber angle, corneal thickness and optic nerve fiber thickness one time.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        POAG group :20 cases normal control group:20 cases
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria（POAG patients）

          1. ages of 18 and 40 years.

          2. glaucoma diagnostic criteria: a) intraocular pressure(IOP) ≥ 21mmhg; b) glaucoma
             specific changes of optic papilla and retinal nerve fiber layer defect;c) glaucoma
             specific visual field defect; d) the anterior chamber angles are open.

          3. without other eye diseases.

          4. Written informed consent.

        Inclusion Criteria（Healthy Volunteers）:

          1. ages of 18 and 40 years.

          2. eye examinations of best corrected visual acuity ≥20/20.

          3. the equivalent degree of myopia &lt; -6.00d.

          4. IOP &lt; 21 mmHg.

          5. without other eye diseases;

          6. Written informed consent.

        Exclusion Criteria（POAG patients and Healthy Volunteers）:

          1. ages over 40 years or less than 18 years.

          2. myopic degree (equivalent refraction) is greater than 6.0D.

          3. history of ocular trauma and ocular surgery.

          4. with other eye diseases: corneal diseases, cataract, diabetic retinopathy and optic
             nerve diseases.

          5. brain injury and other diseases of the nervous system: Alzheimer's disease,
             Parkinson's disease.

          6. MRI scan showed that there was a qualitative change: cerebral infarction, cerebral
             thrombosis, etc.

          7. install cardiac pacemakers, claustrophobic patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qing Zhou, MD</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital of Jinan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qing Zhou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Jinan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qing Zhou, MD</last_name>
    <phone>86-18928903759</phone>
    <email>kerryzh@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaoyong Liu, MD</last_name>
    <phone>86-20-38688350</phone>
    <email>jndxlxy@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Affiliated Hospital of Jinan University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510632</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qing Zhou, MD</last_name>
      <phone>86-18928903759</phone>
      <email>kerryzh@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiaoyong Liu, MD</last_name>
      <phone>86-20-38688350</phone>
      <email>jndxlxy@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Qing Zhou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaoyong Liu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Quigley HA. Glaucoma. Lancet. 2011 Apr 16;377(9774):1367-77. doi: 10.1016/S0140-6736(10)61423-7. Epub 2011 Mar 30. Review.</citation>
    <PMID>21453963</PMID>
  </reference>
  <reference>
    <citation>He M, Foster PJ, Ge J, Huang W, Zheng Y, Friedman DS, Lee PS, Khaw PT. Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2782-8.</citation>
    <PMID>16799014</PMID>
  </reference>
  <reference>
    <citation>Gupta N, Yücel YH. What changes can we expect in the brain of glaucoma patients? Surv Ophthalmol. 2007 Nov;52 Suppl 2:S122-6. doi: 10.1016/j.survophthal.2007.08.006. Review.</citation>
    <PMID>17998036</PMID>
  </reference>
  <reference>
    <citation>Ito Y, Shimazawa M, Chen YN, Tsuruma K, Yamashima T, Araie M, Hara H. Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeys. Exp Eye Res. 2009 Aug;89(2):246-55. doi: 10.1016/j.exer.2009.03.013. Epub 2009 Mar 31.</citation>
    <PMID>19341728</PMID>
  </reference>
  <reference>
    <citation>Gupta N, Ang LC, Noël de Tilly L, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006 Jun;90(6):674-8. Epub 2006 Feb 7.</citation>
    <PMID>16464969</PMID>
  </reference>
  <reference>
    <citation>Murai H, Suzuki Y, Kiyosawa M, Tokumaru AM, Ishii K, Mochizuki M. Positive correlation between the degree of visual field defect and optic radiation damage in glaucoma patients. Jpn J Ophthalmol. 2013 May;57(3):257-62. doi: 10.1007/s10384-013-0233-0. Epub 2013 Feb 16.</citation>
    <PMID>23417328</PMID>
  </reference>
  <reference>
    <citation>Qing G, Zhang S, Wang B, Wang N. Functional MRI signal changes in primary visual cortex corresponding to the central normal visual field of patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4627-34. doi: 10.1167/iovs.09-4834. Epub 2010 Mar 31.</citation>
    <PMID>20357191</PMID>
  </reference>
  <reference>
    <citation>Chen WW, Wang N, Cai S, Fang Z, Yu M, Wu Q, Tang L, Guo B, Feng Y, Jonas JB, Chen X, Liu X, Gong Q. Structural brain abnormalities in patients with primary open-angle glaucoma: a study with 3T MR imaging. Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):545-54. doi: 10.1167/iovs.12-9893.</citation>
    <PMID>23258150</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>October 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <last_update_submitted>October 7, 2015</last_update_submitted>
  <last_update_submitted_qc>October 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Jinan University</investigator_affiliation>
    <investigator_full_name>Qing Zhou</investigator_full_name>
    <investigator_title>Vice director of Department of Ophthalmology The First Affiliated Hospital of Jinan University</investigator_title>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>brain function</keyword>
  <keyword>fMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

